Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
MRAI Stock Summary
Top 10 Correlated ETFs
MRAI
In the News
More Big Warren Buffett Purchases Highlight Recent Insider Buying
The number of notable insider purchases in mid-January may have been somewhat small, but a couple from the Oracle of Omaha made headlines.
MARPAI TO HOST INVESTOR WEBCAST ON NOVEMBER 29, 2023
NEW YORK , Nov. 23, 2023 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (Nasdaq: MRAI), an independent national Third-Party Administrator (TPA) company transforming the $22 billion TPA market supporting self-funded employer health plans will host an Investors Webcast on Wednesday, November 29 at 8:00 a.m. ET. Key topics will include the recent management and leadership changes, the withdrawal of the Company's S-1 Registration, current initiatives, and the Company's strategic vision.
Why Is Marpai (MRAI) Stock Up 100% Today?
Marpai (NASDAQ: MRAI ) stock is heading higher on Friday after the healthcare company announced changes to its leadership team. First off, Marpai announced that current Board of Directors member Damien Lamendola is taking over as the CEO of the company.
Marpai, Inc. (MRAI) Q2 2023 Earnings Call Transcript
Marpai, Inc. (NASDAQ:MRAI ) Q2 2023 Earnings Conference Call August 3, 2023 8:30 AM ET Company Participants Simon Li - Vice President Edmundo Gonzalez - Chief Executive Officer Yoram Bibring - Chief Financial Officer Conference Call Participants Allen Klee - Maxim Group Operator Good day. And thank you for standing by.
Why Is Marpai (MRAI) Stock Down 40% Today?
Marpai (NASDAQ: MRAI ) stock is taking a beating on Monday after the company announced a proposed public offering for its shares. Marpai announced the proposed public offering after markets closed on Friday.
Finding Rising Penny Stocks, 3 Tips for Success
Use these tips to find rising penny stocks The post Finding Rising Penny Stocks, 3 Tips for Success appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Marpai, Inc. (MRAI) Q3 2022 Earnings Call Transcript
Marpai, Inc. (NASDAQ:MRAI ) Q3 2022 Earnings Conference Call November 10, 2022 8:30 AM ET Company Participants Edmundo Gonzalez - Co-Founder, CEO, Secretary & Director Yoram Bibring - CFO Conference Call Participants Allen Klee - Maxim Group Operator Good day, and thank you for standing by. Welcome to the Marpai Second Quarter 2022 Earnings Conference Call in which management will also discuss the Maestro Health acquisition.
OncoCyte And 2 Other Stocks Under $1 Insiders Are Aggressively Buying
The Dow Jones dropped by around 170 points on Wednesday following the release of Fed minutes. Investors, meanwhile, focused on some notable insider trades.
Marpai, Inc. (MRAI) CEO Edmundo Gonzalez on Q2 2022 Results - Earnings Call Transcript
Marpai, Inc. (NASDAQ:MRAI ) Q2 2022 Earnings Conference Call August 11, 2022 8:30 AM ET Company Participants Simon Li – Vice President Edmundo Gonzalez – Chief Executive Officer, Secretary and Director Yoram Bibring – Chief Financial Officer Conference Call Participants Allen Klee – Maxim Group Operator Good day and thank you for standing by. Welcome to the Marpai Second Quarter 2022 Earnings Conference Call in which management will also discuss the Maestro Health acquisition.
Marpai, Inc. (MRAI) CEO Edmundo Gonzalez on Q1 2022 Results - Earnings Call Transcript
Marpai, Inc. (NASDAQ:MRAI ) Q1 2022 Earnings Conference Call May 12, 2022 8:30 AM ET Company Participants Yoram Bibring - Chief Financial Officer Edmundo Gonzalez - Chief Executive Officer Conference Call Participants Operator Good morning and welcome to the Marpai's First Quarter 2022 Financial Results Conference Call. All participants will be in a listen only mode.
MRAI Financial details
MRAI Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 5.65 | 1.2 | |
Net income per share | -0.33 | -0.96 | -6.35 | -1.31 | |
Operating cash flow per share | -0.17 | -0.43 | -4.29 | -1.74 | |
Free cash flow per share | -0.25 | -0.56 | -4.98 | -1.79 | |
Cash per share | 0.04 | 0.38 | 7.61 | 0.68 | |
Book value per share | -0.17 | -0.76 | 11.79 | 0.3 | |
Tangible book value per share | -0.82 | -1.6 | 6.16 | -0.52 | |
Share holders equity per share | -0.17 | -0.76 | 11.79 | 0.3 | |
Interest debt per share | 1.02 | 2.15 | 1 | 0.31 | |
Market cap | 95.58M | 87.06M | 44.14M | 58.29M | |
Enterprise value | 100.4M | 94.65M | 27.04M | 50.61M | |
P/E ratio | -57.14 | -19.72 | -2.76 | -2.2 | |
Price to sales ratio | 0 | 0 | 3.1 | 2.39 | |
POCF ratio | -109.16 | -44.66 | -4.09 | -1.65 | |
PFCF ratio | -76.24 | -34.15 | -3.52 | -1.61 | |
P/B Ratio | -109.47 | -24.9 | 1.49 | 9.5 | |
PTB ratio | -109.47 | -24.9 | 1.49 | 9.5 | |
EV to sales | 0 | 0 | 1.9 | 2.08 | |
Enterprise value over EBITDA | -66.27 | -29.67 | -1.98 | -2.27 | |
EV to operating cash flow | -114.66 | -48.55 | -2.5 | -1.44 | |
EV to free cash flow | -80.08 | -37.13 | -2.16 | -1.4 | |
Earnings yield | -0.02 | -0.05 | -0.36 | -0.45 | |
Free cash flow yield | -0.01 | -0.03 | -0.28 | -0.62 | |
Debt to equity | -5.73 | -2.67 | 0.07 | 0.99 | |
Debt to assets | 1.18 | 1.43 | 0.05 | 0.12 | |
Net debt to EBITDA | -3.18 | -2.38 | 1.25 | 0.34 | |
Current ratio | 1.46 | 0.82 | 2.42 | 1.53 | |
Interest coverage | -14.84 | -6.46 | -37.15 | -99.57 | |
Income quality | 0.52 | 0.5 | 0.68 | 1.33 | |
Dividend Yield | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0.57 | 0.51 | |
Research and developement to revenue | 0 | 0 | 0.12 | 0.15 | |
Intangibles to total assets | 0.77 | 0.58 | 0.32 | 0.34 | |
Capex to operating cash flow | 0.43 | 0.31 | 0.16 | 0.03 | |
Capex to revenue | 0 | 0 | -0.12 | -0.04 | |
Capex to depreciation | -5.29 | -3.94 | -0.84 | -0.23 | |
Stock based compensation to revenue | 0 | 0 | 0.09 | 0.13 | |
Graham number | 1.14 | 4.07 | 41.03 | 2.99 | |
ROIC | -0.35 | -0.62 | -0.46 | -1.43 | |
Return on tangible assets | -1.69 | -1.63 | -0.53 | -0.8 | |
Graham Net | -0.97 | -1.78 | 3.3 | -1.19 | |
Working capital | 90.88K | -469.03K | 15.85M | 9.18M | |
Tangible asset value | -4.12M | -7.32M | 15.51M | -10.62M | |
Net current asset value | -4.82M | -7.85M | 12.5M | -17.28M | |
Invested capital | -5.73 | -2.67 | 0.07 | 0.99 | |
Average receivables | 0 | 63.95K | 207.52K | 1.07M | |
Average payables | 0 | 109.89K | 650.45K | 1.29M | |
Average inventory | 0 | 61.15K | 3.41M | 8.05M | |
Days sales outstanding | 0 | 0 | 8.08 | 27.28 | |
Days payables outstanding | 229.22 | 418.96 | 39.94 | 31.06 | |
Days of inventory on hand | 301.02 | 151.79 | 239.47 | 199.22 | |
Receivables turnover | 0 | 0 | 45.17 | 13.38 | |
Payables turnover | 1.59 | 0.87 | 9.14 | 11.75 | |
Inventory turnover | 1.21 | 2.4 | 1.52 | 1.83 | |
ROE | 1.92 | 1.26 | -0.54 | -4.32 | |
Capex per share | -0.08 | -0.13 | -0.69 | -0.05 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.24 | 0.37 | 0.46 | 1.47 | 1.17 | |
Net income per share | -0.28 | -0.41 | -0.45 | -1.1 | -0.98 | |
Operating cash flow per share | -0.26 | -0.96 | -0.31 | -0.32 | -0.88 | |
Free cash flow per share | -0.27 | -0.97 | -0.31 | -0.32 | -0.88 | |
Cash per share | 0.23 | 0.66 | 0.29 | 1.27 | 0.4 | |
Book value per share | 0.69 | 0.3 | -0.09 | -0.39 | -1.24 | |
Tangible book value per share | 0.06 | -0.51 | -0.84 | -2.61 | -3.14 | |
Share holders equity per share | 0.69 | 0.3 | -0.09 | -0.39 | -1.24 | |
Interest debt per share | 0.08 | 0.3 | 0.29 | 0.74 | 0.64 | |
Market cap | 84.65M | 59.65M | 84.65M | 11.7M | 4.94M | |
Enterprise value | 81.48M | 51.96M | 84.2M | 7.72M | 6.34M | |
P/E ratio | -3.68 | -1.76 | -2.2 | -0.39 | -0.17 | |
Price to sales ratio | 17.14 | 7.82 | 8.75 | 1.16 | 0.57 | |
POCF ratio | -16.23 | -3 | -12.94 | -5.32 | -0.75 | |
PFCF ratio | -15.46 | -2.98 | -12.95 | -5.32 | -0.75 | |
P/B Ratio | 6.05 | 9.72 | -44.3 | -4.39 | -0.53 | |
PTB ratio | 6.05 | 9.72 | -44.3 | -4.39 | -0.53 | |
EV to sales | 16.5 | 6.81 | 8.71 | 0.77 | 0.73 | |
Enterprise value over EBITDA | -18.24 | -6.89 | -11.73 | -1.31 | -1.41 | |
EV to operating cash flow | -15.62 | -2.61 | -12.87 | -3.51 | -0.96 | |
EV to free cash flow | -14.88 | -2.6 | -12.88 | -3.51 | -0.96 | |
Earnings yield | -0.07 | -0.14 | -0.11 | -0.65 | -1.48 | |
Free cash flow yield | -0.06 | -0.34 | -0.08 | -0.19 | -1.33 | |
Debt to equity | 0.11 | 0.99 | -2.99 | -1.78 | -0.48 | |
Debt to assets | 0.06 | 0.12 | 0.14 | 0.11 | 0.12 | |
Net debt to EBITDA | 0.71 | 1.02 | 0.06 | 0.68 | -0.31 | |
Current ratio | 1.2 | 1.53 | 1.15 | 1.07 | 0.82 | |
Interest coverage | -2K | -38.35 | -22.14 | -21.82 | -18.31 | |
Income quality | 0.9 | 2.33 | 0.74 | 0.29 | 0.9 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.55 | 0.57 | 0.54 | 0.57 | 0.57 | |
Research and developement to revenue | 0.16 | 0.13 | 0.05 | 0.05 | 0.03 | |
Intangibles to total assets | 0.5 | 0.34 | 0.38 | 0.35 | 0.4 | |
Capex to operating cash flow | 0.05 | 0 | 0 | 0 | 0 | |
Capex to revenue | -0.05 | -0.01 | 0 | 0 | 0 | |
Capex to depreciation | -0.2 | -0.07 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0.14 | 0.09 | 0.06 | 0.04 | 0.1 | |
Graham number | 2.09 | 1.65 | 0.96 | 3.11 | 5.21 | |
ROIC | -0.34 | -0.45 | -0.97 | -1.18 | 18.04 | |
Return on tangible assets | -0.45 | -0.26 | -0.36 | -0.26 | -0.34 | |
Graham Net | -0.2 | -1.16 | -1.47 | -4.43 | -4.68 | |
Working capital | 1.69M | 9.18M | 2.62M | 1.52M | -3.63M | |
Tangible asset value | 1.26M | -10.62M | -17.81M | -17.84M | -23.52M | |
Net current asset value | -1.08M | -17.28M | -24.06M | -22.64M | -28.04M | |
Invested capital | 0.11 | 0.99 | -2.99 | -1.78 | -0.48 | |
Average receivables | 145.68K | 1.04M | 1.95M | 1.92M | 1.68M | |
Average payables | 591.46K | 1.08M | 1.78M | 2.13M | 2.62M | |
Average inventory | 5.54M | 7.16M | 9.88M | 11.25M | 11.67M | |
Days sales outstanding | 4.82 | 21.46 | 19.29 | 15.76 | 16.54 | |
Days payables outstanding | 17.2 | 27.26 | 29.65 | 30.05 | 49.04 | |
Days of inventory on hand | 123.29 | 174.9 | 146.14 | 169.39 | 177.64 | |
Receivables turnover | 18.68 | 4.19 | 4.67 | 5.71 | 5.44 | |
Payables turnover | 5.23 | 3.3 | 3.04 | 2.99 | 1.84 | |
Inventory turnover | 0.73 | 0.51 | 0.62 | 0.53 | 0.51 | |
ROE | -0.41 | -1.38 | 5.03 | 2.83 | 0.79 | |
Capex per share | -0.01 | 0 | 0 | 0 | 0 |
MRAI Frequently Asked Questions
What is Marpai, Inc. stock symbol ?
Marpai, Inc. is a US stock , located in New york of Ny and trading under the symbol MRAI
What is Marpai, Inc. stock quote today ?
Marpai, Inc. stock price is $2.5 today.
Is Marpai, Inc. stock public?
Yes, Marpai, Inc. is a publicly traded company.